INSM logo

Insmed, Inc.

INSM

INSM: Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

more

Show INSM Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of INSM by members of U.S. Congress

Politician Type Traded
Josh Gottheimer House / D Purchase $1,001 - $15,000 Dec. 06, 2022
Whale Activity

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by INSM's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $50,000 Apr 18, 2019 Issue: Health Issues
  • $50,000 Jan 18, 2019 Issue: Health Issues
  • $50,000 Oct 16, 2018 Issue: Health Issues
  • $50,000 Jul 19, 2018 Issue: Health Issues
  • $50,000 Apr 19, 2018 Issue: Health Issues
  • $22,500 Jul 20, 2011 Issue: Pharmacy
  • $22,500 Apr 11, 2011 Issue: Pharmacy
  • $22,500 Jan 17, 2011 Issue: Pharmacy
  • $22,500 Oct 12, 2010 Issue: Pharmacy
  • $22,500 Jul 20, 2010 Issue: Pharmacy
  • $22,500 May 27, 2010 Issue: Pharmacy
  • $22,500 Jan 14, 2010 Issue: Pharmacy
  • $22,500 Oct 20, 2009 Issue: Pharmacy
  • $22,500 Jul 15, 2009 Issue: Pharmacy
  • $22,500 Jul 15, 2009 Issue: Pharmacy
  • $22,500 Oct 31, 2008 Issue: Pharmacy
  • $22,500 Jul 08, 2008 Issue: Pharmacy
  • $22,500 Apr 15, 2008 Issue: Pharmacy
  • $22,500 Apr 13, 2008 Issue: Pharmacy
  • $140,000 Feb 01, 2007 Issue: Health Issues
  • $160,000 Aug 08, 2006 Issue: Health Issues
  • $40,000 Feb 13, 2006 Issue: Health Issues
U.S. Patents

New patents grants

  • Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Sep. 19, 2023
  • Patent Title: Antibodies and methods of making same May. 16, 2023
  • Patent Title: Methods for continuous manufacture of liposomal drug products Feb. 07, 2023
  • Patent Title: Dry powder compositions of treprostinil prodrugs and methods of use thereof Oct. 04, 2022
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Sep. 20, 2022
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Jul. 26, 2022
  • Patent Title: Methods of manufacturing treprostinil and treprostinil derivative prodrugs Oct. 19, 2021
  • Patent Title: Lipo-glycopeptide cleavable derivatives and uses thereof Jul. 27, 2021
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof May. 04, 2021
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Nov. 10, 2020
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Aug. 25, 2020
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Mar. 17, 2020
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Jan. 07, 2020
  • Patent Title: Stabilized vancomycin formulations Nov. 12, 2019
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Sep. 03, 2019
  • Patent Title: Methods of manufacturing treprostinil and treprostinil derivative prodrugs Jul. 09, 2019
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jun. 25, 2019
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Apr. 09, 2019
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Mar. 26, 2019
  • Patent Title: Stabilized vancomycin formulations Nov. 13, 2018
  • Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Sep. 04, 2018
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Jul. 03, 2018
  • Patent Title: Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods of use thereof Mar. 27, 2018
  • Patent Title: Methods for treating pulmonary non-tuberculous mycobacterial infections Feb. 20, 2018
  • Patent Title: Sustained release of antiinfectives Nov. 28, 2017
  • Patent Title: Method of treating pulmonary disorders with liposomal amikacin formulations Aug. 22, 2017
  • Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Aug. 08, 2017
  • Patent Title: Systems for treating pulmonary infections Feb. 14, 2017
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 24, 2017
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 24, 2017
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Dec. 06, 2016
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Oct. 18, 2016
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Aug. 02, 2016
  • Patent Title: Method for treating pulmonary disorders with liposomal amikacin formulations May. 10, 2016
  • Patent Title: Prostacyclin compounds, compositions and methods of use thereof Feb. 09, 2016
  • Patent Title: Platinum aggregates and process for producing the same Nov. 17, 2015
  • Patent Title: Method of treating pulmonary disorders with liposomal amikacin formulations Sep. 01, 2015
  • Patent Title: Methods of treating pulmonary disorders with liposomal amikacin formulations Aug. 25, 2015
  • Patent Title: Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally Aug. 18, 2015
  • Patent Title: Sustained release of antiinfectives Aug. 12, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 25, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 18, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Mar. 18, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Feb. 04, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jan. 21, 2014
  • Patent Title: Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof Jul. 24, 2012
  • Patent Title: Purified rhigf-i/rhigfbp-3 complexes and their method of manufacture Jun. 28, 2011
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of INSM in WallStreetBets Daily Discussion

INSM News

Recent insights relating to INSM

CNBC Recommendations

Recent picks made for INSM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INSM

Corporate Flights

Flights by private jets registered to INSM